Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Citicoline on Barthel Index in Patients with Moderate and Severe Traumatic Brain Injury
IRCT20200609047706N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of citicoline in traumatic brain injury (TBI), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Barthel Index. Started Jun 2020; status: completed.
02
Drugs
citicoline
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on IRCT20200609047706N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200609047706N1.